Synthesis and biological evaluation of new amino acid and dipeptide derivatives of neocryptolepine as anticancer agents. 2012

Katarzyna Sidoryk, and Marta Switalska, and Joanna Wietrzyk, and Anna Jaromin, and Magdalena Piętka-Ottlik, and Piotr Cmoch, and Joanna Zagrodzka, and Wojciech Szczepek, and Lukasz Kaczmarek, and Wanda Peczyńska-Czoch
Pharmaceutical Research Institute, Rydygiera 8, 01-793 Warszawa, Poland. k.sidoryk@ifarm.eu

The syntheses of neocryptolepine derivatives containing an amino acid or a dipeptide at the C-9 position and their evaluation for antitumor activity in vitro and in vivo are reported. To establish the influence of an amino acid or a peptide on the physicochemical properties of 5H-indolo[2,3-b]quinoline (DiMIQ), lipophilic and hemolytic properties were investigated. Most of the compounds displayed a high antiproliferative activity in vitro and strongly inhibited growth of tumor in mice compared to cyclophosphamide. The attachment of the hydrophilic amino acid or the peptide to the hydrophobic DiMIQ increased its hydrophilic properties and decreased its hemolytic activity. The glycylglycine conjugate (7a) was the most promising derivative. It strongly inhibited the growth of the tumor in mice (at dose 50 mg kg(-1) day(-1) it inhibited the tumor growth by 46-63% on days 11-16 and by 29-43% on days 18-23) and significantly decreased hemolytic activity and lowered the in vivo toxicity compared to DiMIQ.

UI MeSH Term Description Entries
D011804 Quinolines
D002243 Carbolines A group of pyrido-indole compounds. Included are any points of fusion of pyridine with the five-membered ring of indole and any derivatives of these compounds. These are similar to CARBAZOLES which are benzo-indoles. Carboline,Pyrido(4,3-b)Indole,Beta-Carbolines,Pyrido(4,3-b)Indoles,Beta Carbolines
D004151 Dipeptides Peptides composed of two amino acid units. Dipeptide
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006461 Hemolysis The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity. Haemolysis,Extravascular Hemolysis,Intravascular Hemolysis,Extravascular Hemolyses,Haemolyses,Hemolyses, Extravascular,Hemolyses, Intravascular,Hemolysis, Extravascular,Hemolysis, Intravascular,Intravascular Hemolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000470 Alkaloids Organic nitrogenous bases. Many alkaloids of medical importance occur in the animal and vegetable kingdoms, and some have been synthesized. (Grant & Hackh's Chemical Dictionary, 5th ed) Alkaloid,Plant Alkaloid,Plant Alkaloids,Alkaloid, Plant,Alkaloids, Plant
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy

Related Publications

Katarzyna Sidoryk, and Marta Switalska, and Joanna Wietrzyk, and Anna Jaromin, and Magdalena Piętka-Ottlik, and Piotr Cmoch, and Joanna Zagrodzka, and Wojciech Szczepek, and Lukasz Kaczmarek, and Wanda Peczyńska-Czoch
February 2023, RSC medicinal chemistry,
Katarzyna Sidoryk, and Marta Switalska, and Joanna Wietrzyk, and Anna Jaromin, and Magdalena Piętka-Ottlik, and Piotr Cmoch, and Joanna Zagrodzka, and Wojciech Szczepek, and Lukasz Kaczmarek, and Wanda Peczyńska-Czoch
January 2020, European journal of medicinal chemistry,
Katarzyna Sidoryk, and Marta Switalska, and Joanna Wietrzyk, and Anna Jaromin, and Magdalena Piętka-Ottlik, and Piotr Cmoch, and Joanna Zagrodzka, and Wojciech Szczepek, and Lukasz Kaczmarek, and Wanda Peczyńska-Czoch
October 2022, International journal of molecular sciences,
Katarzyna Sidoryk, and Marta Switalska, and Joanna Wietrzyk, and Anna Jaromin, and Magdalena Piętka-Ottlik, and Piotr Cmoch, and Joanna Zagrodzka, and Wojciech Szczepek, and Lukasz Kaczmarek, and Wanda Peczyńska-Czoch
February 2021, Molecules (Basel, Switzerland),
Katarzyna Sidoryk, and Marta Switalska, and Joanna Wietrzyk, and Anna Jaromin, and Magdalena Piętka-Ottlik, and Piotr Cmoch, and Joanna Zagrodzka, and Wojciech Szczepek, and Lukasz Kaczmarek, and Wanda Peczyńska-Czoch
March 2014, European journal of medicinal chemistry,
Katarzyna Sidoryk, and Marta Switalska, and Joanna Wietrzyk, and Anna Jaromin, and Magdalena Piętka-Ottlik, and Piotr Cmoch, and Joanna Zagrodzka, and Wojciech Szczepek, and Lukasz Kaczmarek, and Wanda Peczyńska-Czoch
April 2020, Future medicinal chemistry,
Katarzyna Sidoryk, and Marta Switalska, and Joanna Wietrzyk, and Anna Jaromin, and Magdalena Piętka-Ottlik, and Piotr Cmoch, and Joanna Zagrodzka, and Wojciech Szczepek, and Lukasz Kaczmarek, and Wanda Peczyńska-Czoch
June 2009, Journal of enzyme inhibition and medicinal chemistry,
Katarzyna Sidoryk, and Marta Switalska, and Joanna Wietrzyk, and Anna Jaromin, and Magdalena Piętka-Ottlik, and Piotr Cmoch, and Joanna Zagrodzka, and Wojciech Szczepek, and Lukasz Kaczmarek, and Wanda Peczyńska-Czoch
December 2012, European journal of medicinal chemistry,
Katarzyna Sidoryk, and Marta Switalska, and Joanna Wietrzyk, and Anna Jaromin, and Magdalena Piętka-Ottlik, and Piotr Cmoch, and Joanna Zagrodzka, and Wojciech Szczepek, and Lukasz Kaczmarek, and Wanda Peczyńska-Czoch
October 2019, Molecules (Basel, Switzerland),
Katarzyna Sidoryk, and Marta Switalska, and Joanna Wietrzyk, and Anna Jaromin, and Magdalena Piętka-Ottlik, and Piotr Cmoch, and Joanna Zagrodzka, and Wojciech Szczepek, and Lukasz Kaczmarek, and Wanda Peczyńska-Czoch
March 2010, Oncology letters,
Copied contents to your clipboard!